Formulated with 4% Niacinamide

Dong-A Pharmaceutical announced on September 18 that it has launched 'Akrinvitagel,' an acne treatment containing 4% niacinamide as its main ingredient.


Niacinamide, a form of vitamin B3, is known to regulate sebum secretion and inhibit the production of inflammatory mediators. With 4% niacinamide, Akrinvitagel helps control excessive sebum secretion and manage inflammation.

Dong-A Pharmaceutical Acne Treatment 'Accrinvitagel'. Dong-A Pharmaceutical

Dong-A Pharmaceutical Acne Treatment 'Accrinvitagel'. Dong-A Pharmaceutical

View original image

Akrinvitagel is a new addition to Dong-A Pharmaceutical's acne treatment brand 'Acne.' The Acne brand provides customized treatment solutions tailored to symptoms and causes, reflecting the fact that acne develops from a complex interplay of factors, including sebum secretion, excessive keratinization of the pores, proliferation of acne-causing bacteria, and inflammation.



A representative from Dong-A Pharmaceutical stated, "We will continue to further segment and strengthen the acne treatment solutions offered by the Acne brand."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing